We are part of the CSL Limited group of companies. See how we're Driven by Our Promise.
We collaborate with rare disease organizations to promote quality medical care and services.
We offer a variety of support programs and activities for the patients we serve.
We also aim to make sure that nothing holds you back from getting the therapies you need.
Our product portfolio focuses on innovation in new products, improved products and manufacturing expertise.
A clinical trial is a research study that is done to find out if medical treatments can improve people’s health.
We work every day as if someone’s life depends on it, because it does.
We manufacture products to treat a number of rare diseases.
Help us deliver on our promise to save lives and protect the health of people.
Diversity and inclusion are top priorities for CSL Behring.
A global network of hemophilia treatment centers offer comprehensive care and access to the latest treatments.
Behind the trendy term, there’s a commonsense concept that can make a difference for patients living with chronic illness.
As measles cases continue in the U.S., make sure children are protected, public health officials say.
Replacing C1-INH plasma protein gives a rare disease a longed-for treatment.
Tapping all sources of data gives a fuller picture of patient experience.
Women who have the bleeding disorder often go undiagnosed, Duke doctor says.
Clinical trials play an important role in biotechnology. Our infographic tells why.
How can we improve access to treatment for patients?
Below a soccer field, CSL Behring’s manufacturing site in Bern goes green.
Popular search terms:
Americas
Asia Pacific
Europe
